Empowered Funds, LLC Corcept Therapeutics Inc Transaction History

Empowered Funds, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$62.24 - $91.93 $7.44 Million - $11 Million	-119,493 Reduced 97.67%	2,852 $209,000
Q1 2025 May 16, 2025	BUY	$49.85 - $114.22 $4.05 Million - $9.29 Million	81,297 Added 198.05%	122,345 $14 Million
Q4 2024 Jan 28, 2025	BUY	$44.66 - $60.85 $111,962 - $152,550	2,507 Added 6.5%	41,048 $2.07 Million
Q3 2024 Nov 06, 2024	BUY	$29.51 - $46.26 $1.14 Million - $1.78 Million	38,541 New	38,541 $1.78 Million
Q4 2022 Jan 26, 2023	BUY	$19.95 - $29.96 $605,741 - $909,675	30,363 New	30,363 $617,000

Q3 2020 Oct 26, 2020	SELL	$12.46 - $19.98 $2.17 Million - $3.48 Million	-174,010 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$11.0 - $18.26 $1.91 Million - $3.18 Million	174,010 New	174,010 $2.93 Million

480

80.5M

596K

710K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $8.09B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

Stay updated on Empowered Funds, LLC with notifications on news.